Cyanosis resident survival guide (pediatrics): Difference between revisions
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 162: | Line 162: | ||
*Shown below is an algorithm summarizing the [[treatment]] of [[cyanosis]]:<ref name="Dasgupta Bhargava Huff Jiwani pp. e598–e604">{{cite journal | last=Dasgupta | first=Soham | last2=Bhargava | first2=Vidit | last3=Huff | first3=Monica | last4=Jiwani | first4=Amyn K. | last5=Aly | first5=Ashraf M. | title=Evaluation of The Cyanotic Newborn: Part I—A Neonatologist’s Perspective | journal=NeoReviews | publisher=American Academy of Pediatrics (AAP) | volume=17 | issue=10 | date=2016-09-30 | issn=1526-9906 | doi=10.1542/neo.17-10-e598 | pages=e598–e604}}</ref><ref name="NCBI Bookshelf 2010">{{cite web | title=Congenital Heart Disease | website=NCBI Bookshelf | date=2010-07-22 | url=https://www.ncbi.nlm.nih.gov/books/NBK209965/ | access-date=2020-10-13}}</ref> | *Shown below is an algorithm summarizing the [[treatment]] of [[cyanosis]]:<ref name="Dasgupta Bhargava Huff Jiwani pp. e598–e604">{{cite journal | last=Dasgupta | first=Soham | last2=Bhargava | first2=Vidit | last3=Huff | first3=Monica | last4=Jiwani | first4=Amyn K. | last5=Aly | first5=Ashraf M. | title=Evaluation of The Cyanotic Newborn: Part I—A Neonatologist’s Perspective | journal=NeoReviews | publisher=American Academy of Pediatrics (AAP) | volume=17 | issue=10 | date=2016-09-30 | issn=1526-9906 | doi=10.1542/neo.17-10-e598 | pages=e598–e604}}</ref><ref name="NCBI Bookshelf 2010">{{cite web | title=Congenital Heart Disease | website=NCBI Bookshelf | date=2010-07-22 | url=https://www.ncbi.nlm.nih.gov/books/NBK209965/ | access-date=2020-10-13}}</ref> | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | A01 |A01= [[Treatment]] depends upon the [[etiology]] of [[cyanosis]] | {{familytree | | | | | | | | A01 |A01= [[Treatment]] depends upon the [[etiology]] of [[cyanosis]]}} | ||
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | {{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | ||
{{familytree | | | B01 | | | | | | | | B02 | | |B01=[[Respiratory]] Compromise |B02=No [[Respiratory]] Compromise }} | {{familytree | | | B01 | | | | | | | | B02 | | |B01=[[Respiratory]] Compromise |B02=No [[Respiratory]] Compromise }} | ||
Line 168: | Line 168: | ||
{{familytree | | | C01 | | | | | | | |C02| |C01= | {{familytree | | | C01 | | | | | | | |C02| |C01= | ||
*An adequate [[airway]] should be established and supplemental [[oxygen]] is given.<br> | *An adequate [[airway]] should be established and supplemental [[oxygen]] is given.<br> | ||
*Continuous positive airway pressure (CPAP) or intubation for positive pressure ventilation can be done for infants with respiratory distress and carbon dioxide retention.<br> | *[[Continuous positive airway pressure]] (CPAP) or [[intubation]] for [[positive pressure ventilation]] can be done for [[infants]] with [[respiratory distress]] and [[carbon dioxide]] retention.<br> | ||
*If there is airway obstruction prone positioning or oral airway is established to relieve cyanosis.<br> | *If there is an [[airway]] [[obstruction]], [[prone]] positioning or [[oral airway]] is established to relieve [[cyanosis]].<br> | ||
| C02= Depending upon etiology | | C02= Depending upon [[etiology]] | ||
*'''Sepsis: '''Broad-spectrum antibiotics should be initiated such as ampicillin and gentamicin. | *'''[[Sepsis]]: '''[[Broad-spectrum antibiotics]] should be initiated such as [[ampicillin]] and [[gentamicin]]. | ||
Blood cultures should be obtained to identify the causative agent.<br> | [[Blood cultures]] should be obtained to identify the [[causative agent]].<br> | ||
*'''Neonatal Hypoglycemia''': Adequate blood glucose should be maintained in range of >45 to 50 mg/dl. <br> | *'''[[Neonatal]] [[Hypoglycemia]]''': Adequate [[blood glucose]] should be maintained in range of >45 to 50 mg/dl.<br> | ||
*'''Cyanotic Congenital Cardiac Conditions''' should be approached with proper pediatric consultation. <br> | *'''[[Cyanotic]] [[Congenital]] [[Cardiac]] [[Conditions]]''' should be approached with proper [[pediatric]] [[consultation]].<br> | ||
*Prostaglandin E1 should be infused at 0.01-0.05mcg/kg/min.<br>}} | *[[Prostaglandin]] E1 should be infused at 0.01-0.05mcg/kg/min.<br>}} | ||
{{familytree | | | | | | | | | | | | | |!| }} | {{familytree | | | | | | | | | | | | | |!| }} | ||
{{familytree | | |,|-|-|v|-|-|-|v|-|-|-|+|-|-|-|-|v|-|-|-|-|-|v|-|-|-|-|.| }} | {{familytree | | |,|-|-|v|-|-|-|v|-|-|-|+|-|-|-|-|v|-|-|-|-|-|v|-|-|-|-|.| }} | ||
{{familytree |D01| |D02| | |D03| |D04| | |D05| |D06| | |D07| |D01=[[TGA]], [[TAPVR ]],[[Truncus arteriosus]]|D02= [[TOF]]|D03=Ebstein anomaly |D04=[[Hypoplastic left heart syndrome]] |D05=[[Sepsis]], [[shock]], low [[cardiac output]] state, [[cold exposure]], [[metabolic disorder]], [[polycythemia]] |D06=[[Eisenmenger syndrome]] with [[pulmonary hypertension]] |D07=Methemoglobinemia }} | {{familytree |D01| |D02| | |D03| |D04| | |D05| |D06| | |D07| |D01=[[TGA]], [[TAPVR ]],[[Truncus arteriosus]]|D02= [[TOF]]|D03=[[Ebstein anomaly]] |D04=[[Hypoplastic left heart syndrome]] |D05=[[Sepsis]], [[shock]], low [[cardiac output]] state, [[cold exposure]], [[metabolic disorder]], [[polycythemia]] |D06=[[Eisenmenger syndrome]] with [[pulmonary hypertension]] |D07=[[Methemoglobinemia]]}} | ||
{{familytree | |!| | | |!| | | |!| | | |!| | | | |!| | | | |!| | | | | |!||}} | {{familytree | |!| | | |!| | | |!| | | |!| | | | |!| | | | |!| | | | | |!||}} | ||
{{familytree |D01| |D02| | |D03| |D04| |D05| | |D06| | |D07| | |D01= Infusion of [[ | {{familytree |D01| |D02| | |D03| |D04| |D05| | |D06| | |D07| | |D01= [[Infusion]] of [[prostaglandin]], [[diuretic]] [[therapy]], and [[surgery]].<ref name="Rao2013">{{cite journal|last1=Rao|first1=P. Syamasundar|title=Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects|journal=The Indian Journal of Pediatrics|volume=80|issue=8|year=2013|pages=663–674|issn=0019-5456|doi=10.1007/s12098-013-1039-2}}</ref>|D02=[[Infusion]] of [[prostaglandin]] for keeping [[patency]] of [[ductus arteriosus]], [[infusion]] of [[vasodilator]] for reduced [[systemic]] [[resistance]], [[mechanical ventilation]] in [[shock]] state and imposing [[hypercapnia]] and [[alveolar]] [[hypoxia]] for increased [[pulmonary]] [[resistance]]|D03=[[Tricuspid valve]] repair<ref name="pmid31384377">{{cite journal |vauthors=Holst KA, Connolly HM, Dearani JA |title=Ebstein's Anomaly |journal=Methodist Debakey Cardiovasc J |volume=15 |issue=2 |pages=138–144 |date=2019 |pmid=31384377 |pmc=6668741 |doi=10.14797/mdcj-15-2-138 |url=}}</ref>|D04=[[Hypoplastic left heart syndrome]] |D05=[[Treatment]] of underlying [[disorder]]|D06=[[Phosphodiesterase-5 inhibitor]] ([[sildenafil]], [[tadalafil]]). [[Endothelin receptor antagonist]] ([[ bosentan]],[[ macitentan]], [[ambrisentan]]).<ref name="pmid28536680">{{cite journal |vauthors=de Campos FPF, Benvenuti LA |title=Eisenmenger syndrome |journal=Autops Case Rep |volume=7 |issue=1 |pages=5–7 |date=2017 |pmid=28536680 |pmc=5436914 |doi=10.4322/acr.2017.006 |url=}}</ref>|D07=[[Infusion]] of [[methylene blue]], [[dextrose]], N-acetyl cysteine}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 01:39, 28 October 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usman Ali Akbar, M.B.B.S.[2]
Synonyms and keywords: Cyanosis approach in children, Cyanosis workup pediatrics, Cyanosis management in newborn, Approach to blue discoloration of skin in infants, Hypoxemia approach in children, Hypoxia approach in children
Cyanosis resident survival guide (pediatrics) Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
Cyanosis can be defined as bluish discoloration of skin and mucosa and can also be a manifestation of oxygen desaturation of arterial or capillary blood. Cyanosis, hypoxemia, and hypoxia should be differentiated and can occur independently. The causes of cyanosis in a newborn range from congenital cardiac conditions to life-threatening conditions such as exposure to toxic gases or infections leading to sepsis. The management of cyanosis depends upon the etiology and emergent cases with respiratory distress need rapid evaluation and response with immediate establishment of airway access and oxygen support.
Causes
Life-Threatening Causes | Pulmonary Causes | Congenital Cardiac Conditions | Hematological Causes | Peripheral Cyanosis |
---|---|---|---|---|
Decreased inspired FiO2 | ||||
Upper airway obstruction |
Pulmonary vascular disorders | |||
Other Causes |
FIRE: Focused Initial Rapid Evaluation
- Patients presenting to the emergency department with cyanosis and respiratory distress require emergency supplementation of oxygen, use of pulse oximetry and airway, breathing, and circulation support.
- A Focused Initial Rapid Evaluation (FIRE) should be performed to identify the patients in need of immediate intervention.[3]
Patient presents with cyanosis | |||||||||||||||||||||||||||||||||||||||||||||||
No Respiratory Distress | Respiratory Distress | ||||||||||||||||||||||||||||||||||||||||||||||
Peripheral Cyanosis | Central cyanosis | Differential Cyanosis | No Obstruction | Obstruction | |||||||||||||||||||||||||||||||||||||||||||
Reassurance and Warming | Hypoxia Test | Cardiac Evaulation | Hypoxia Test | Give oxygen and Positive Pressure Ventilation | |||||||||||||||||||||||||||||||||||||||||||
PaO2<100 | PaO2 100-150 | PaO2 <100 | PaO2 100-150 | PaO2 >150 | ENT Evaluation | ||||||||||||||||||||||||||||||||||||||||||
Cardiac Evaluation | Persistent pulmonary hypertension of newborn, Cardiac Evaluation | Cardiac Cause | Persistent pulmonary hypertension of newborn | Respiratory management, Give oxygen and positive pressure Ventilation | |||||||||||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
- Shown below is an algorithm summarizing the diagnosis of cyanosis in newborns according to the American Academy of Neonatology guidelines:
Patient presents with cyanosis | |||||||||||||||||
History
| |||||||||||||||||
Physical Examination
| |||||||||||||||||
Diagnostic Studies
| |||||||||||||||||
Treatment
Do's
- Hypoplastic left heart syndrome in infants should be considered with signs and symptoms such as:[8]
- Sudden onset of shock
- Collapse
- Severe academia in the first week of life
- Neonatal sepsis
- Metabolic disorders
- In Ebstein anomaly, repair of tricuspid valve is indicated if the following criteria is met:[6]
- In differential cyanosis, if oxygen saturation of right arm is more than that of legs and improves with oxygen supplemental therapy, then think about the following:
- In the presence of central cyanosis + hemolytic anemia (jaundice, heinz body, fragment RBC) + renal failure, consider diagnosis of methemoglobinemia and treat accordingly.
- Hydration is important in tetralogy of fallot to maintain pulmonary blood flow through atretic pulmonary artery and reducing right to left shunt through VSD.[9]
- If paradoxical embolism is suspected, proceed with a Brain CT scan in the presence of new neurological symptoms in a patient with cyanotic congenital heart disease. It occurs due to passing of emboli from right to left shunt and hyperviscosity ultimately leading to thrombosis.[10]
Don'ts
- There are certain cyanotic congenital heart diseases that are dependent on patent ductus arteriosus (PDA). Don't give indomethacin to patients with the following ductal dependent congenital conditions:
References
- ↑ McMullen, SM; Patrick, W (2013). "Cyanosis". The American journal of medicine. 126 (3): 210–2. doi:10.1016/j.amjmed.2012.11.004. ISSN 0002-9343. PMID 23410559.
- ↑ Sasidharan, Ponthenkandath (2004). "An approach to diagnosis and management of cyanosis and tachypnea in term infants". Pediatric clinics of North America. Elsevier BV. 51 (4): 999–1021. doi:10.1016/j.pcl.2004.03.010. ISSN 0031-3955. PMID 15275985.
- ↑ 3.0 3.1 Dasgupta, Soham; Bhargava, Vidit; Huff, Monica; Jiwani, Amyn K.; Aly, Ashraf M. (2016-09-30). "Evaluation of The Cyanotic Newborn: Part I—A Neonatologist's Perspective". NeoReviews. American Academy of Pediatrics (AAP). 17 (10): e598–e604. doi:10.1542/neo.17-10-e598. ISSN 1526-9906.
- ↑ "Congenital Heart Disease". NCBI Bookshelf. 2010-07-22. Retrieved 2020-10-13.
- ↑ Rao, P. Syamasundar (2013). "Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects". The Indian Journal of Pediatrics. 80 (8): 663–674. doi:10.1007/s12098-013-1039-2. ISSN 0019-5456.
- ↑ 6.0 6.1 Holst KA, Connolly HM, Dearani JA (2019). "Ebstein's Anomaly". Methodist Debakey Cardiovasc J. 15 (2): 138–144. doi:10.14797/mdcj-15-2-138. PMC 6668741 Check
|pmc=
value (help). PMID 31384377. - ↑ de Campos F, Benvenuti LA (2017). "Eisenmenger syndrome". Autops Case Rep. 7 (1): 5–7. doi:10.4322/acr.2017.006. PMC 5436914. PMID 28536680. Vancouver style error: initials (help)
- ↑ Gobergs R, Salputra E, Lubaua I (2016). "Hypoplastic left heart syndrome: a review". Acta Med Litu. 23 (2): 86–98. doi:10.6001/actamedica.v23i2.3325. PMC 5088741. PMID 28356795.
- ↑ O’Brien, Patricia; Marshall, Audrey C. (2014). "Tetralogy of Fallot". Circulation. 130 (4). doi:10.1161/CIRCULATIONAHA.113.005547. ISSN 0009-7322.
- ↑ . doi:10.1161/STROKEAHA.116.012882Stroke. Missing or empty
|title=
(help)